Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 426.00
+0.65 (0.15%)
Jul 31, 2026, 3:30 PM IST
Biocon Stock Forecast
Stock Price Forecast
According to 20 analysts polled by S&P Global, Biocon stock has a consensus rating of "Buy" and an average price target of ₹423.70. The average 1-year stock price forecast is 0.54% lower than the current stock price, while the lowest is ₹290.00 (-31.92%) and the highest is ₹506.00 (+18.78%).
Price Target: ₹423.70 (-0.54%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Feb 17, 2026.
Analyst Ratings
The average analyst rating for Biocon stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 9 | 9 | 8 | 8 | 9 |
| Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Hold | 2 | 2 | 2 | 3 | 3 | 3 |
| Sell | 4 | 4 | 4 | 5 | 5 | 5 |
| Strong Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Total | 19 | 19 | 19 | 20 | 20 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Axis Direct No rating | Axis Direct | Buy Maintains ₹435.00 | Buy | Maintains | ₹435.00 | +2.11% | Feb 17, 2026 |
Financial Forecast
Revenue This Year
200.07B
from 169.27B
Increased by 18.20%
Revenue Next Year
228.83B
from 200.07B
Increased by 14.37%
EPS This Year
7.95
from 5.25
Increased by 51.46%
EPS Next Year
11.67
from 7.95
Increased by 46.82%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.